n.chowdhury

TL2 · Setúbal

Contributes reviews on supplier material. Based in Setúbal.

Joined 9 May 2025 · last posted 3d

74 posts, newest first. Showing up to 150.

Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #53 · Compounds › Repair & healing peptides · 25 Jul 2026 · 11 likes What I would want before treating absence of controlled human data as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the…
Selection into a registry and what it does to the estimate — a second dataset Replied, post #28 · Evidence › Study critique · 23 Jul 2026 · 1 like Selection is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes before…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #93 · Analytics › Impurities & related substances · 19 Jul 2026 · 7 likes This follows post #92 rather than contradicting it. Where an impurity is identified rather than merely counted, the certificate is telling you the manufacturer has…
Sleep quality changes during weight loss Replied, post #21 · Wellbeing › Sleep · 17 Jul 2026 · 15 likes Adding the measurement that post #18 says would settle it. Sleep quality versus quantity: some people report changes to sleep duration; others report changes to sleep…
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #23 · Practice › Dosing & titration · 12 Jul 2026 · 10 likes Worth stating the null on four-week escalation interval before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not…
Conditions that change the calculus rather than forbidding it Replied, post #29 · Safety › Contraindications · 12 Jul 2026 · 1 like Answering the question post #25 raises rather than the one it answers. Careful with the language on conditions. "Not detected" and "not present" are different findings…
What changed in 2026, by region — does this still hold? Replied, post #21 · Access › International · 8 Jul 2026 · 21 likes Currency and exchange rates: paying in different currencies has different costs and risks. Bitcoin eliminates currency and intermediary issues but has other risks. I…
[2026 update] Regional warehouse stock versus direct despatch Replied, post #125 · Sourcing › Logistics · 6 Jul 2026 · 5 likes Before the thread moves on from Regional warehouse stock versus direct — what is the sample size behind the claim? I am not being difficult; I have seen the same figure…
Pooling trials with different estimands Replied, post #45 · Evidence › Meta-analyses · 24 Jun 2026 · 24 likes Taking post #42 at face value and following it one step further. Study quality and weighting: some meta-analyses weight all studies equally; others weight by study size…
Insurance and replacement policies, compared Replied, post #25 · Sourcing › Logistics · 17 Jun 2026 · 21 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
Carryover and the ghost peak from last week's standard — what changed since Replied, post #36 · Analytics › HPLC & UHPLC · 15 Jun 2026 · 0 likes Worth stating the null on Carryover before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get one.
[2026 update] Temperature indicator cards: worth asking for? Replied, post #4 · Sourcing › Logistics · 9 Jun 2026 · 2 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. At what point is a parcel genuinely a problem: if it was despatched weeks…
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #53 · Outcomes › Progress reports · 1 Jun 2026 · 10 likes Rate of change matters more than the absolute number for most of the questions people ask about their own series.
Bioimpedance and hydration: why the number moves Replied, post #49 · Outcomes › Body composition · 23 May 2026 · 9 likes I read post #45 twice before replying, because I had assumed the opposite. I disagree with the framing of bioimpedance and hydration above, and I think it is a…
Alcohol: what is documented and what is folklore Replied, post #24 · Practice › Interactions · 23 May 2026 · 0 likes Saving this. It is the version I will quote when the question comes round again.
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #73 · Compounds › Tirzepatide · 21 May 2026 · 11 likes The five maintenance doses in the tirzepatide programme give a genuine dose-response curve, which is unusual. Most trials in this space compare one or two doses against…
How much fluid is actually needed, and how you would know Replied, post #9 · Nutrition & Training › Hydration & electrolytes · 19 May 2026 · 0 likes Symptoms that resolve quickly with fluid and salt are consistent with a simple explanation, which is worth noting without treating it as proof. This has been discussed…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #65 · Data & Tools › Datasets · 14 May 2026 · 8 likes Independent test results are the most valuable data this community collects, and they are only comparable when the method is captured alongside the number. Noting that…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #57 · Practice › Administration · 4 May 2026 · 8 likes Reading rather than contributing, but this is the most useful thread I have found on it.
Request: show the solution author in the topic list — what changed since Replied, post #55 · Meta › Feature requests · 3 May 2026 · 0 likes Picking up post #52: that is the part I would want checked first. Fair. Then under the name, at a smaller size, permanently.
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #40 · Evidence › Journal club · 25 Apr 2026 · 27 likes I keep a log for indirect comparison specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes cost nothing and…
Hair shedding at month three: mechanism and time course — the long version Started this topic · Practice › Side effects · 17 Apr 2026 · 44 likes Hair shedding at month three: mechanism and time course — the long version Writing it up because I had to work it out twice and would rather nobody else did. Reading…
Sample handling between despatch and injection Replied, post #27 · Analytics › Method validation · 9 Apr 2026 · 0 likes The distinction between a qualified instrument and a validated method is worth keeping. Both are needed and they fail in different ways. A single observation, in a…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #5 · Practice › Reconstitution · 9 Apr 2026 · 32 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #6 · Analytics › Home & field testing · 7 Apr 2026 · 28 likes I would put moderate confidence on the mainstream reading of home kit substitute and no more. That is not scepticism for its own sake; it is where the sourcing actually…
Reused chromatograms across lots: how to spot it — what changed since Replied, post #26 · Analytics › COA interpretation · 24 Mar 2026 · 18 likes The strongest argument against my own position on Reused chromatograms across lots, stated as well as I can state it, since nobody else has yet.
A parcel stationary at a customs facility for nine days — does this still hold? Replied, post #10 · Sourcing › Logistics · 18 Mar 2026 · 22 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. Worth one more sentence than it…
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #17 · Analytics › HPLC & UHPLC · 11 Mar 2026 · 4 likes Post #15 put the caveat in the right place and I want to underline it. Marking my uncertainty on Area percent versus weight percent explicitly. I am confident about the…
Second pass at: Identical chromatograms across two different lots Replied, post #35 · Sourcing › Red flags · 1 Mar 2026 · 6 likes Noted, and I have changed what I was going to do on the strength of it.
What TRIUMPH is designed to answer, and why we should not pre-empt it — does this still… Replied, post #4 · Compounds › Retatrutide · 1 Mar 2026 · 4 likes On the opening post — agreed on the reasoning, with one qualification. Retatrutide is investigational. Anything obtained outside a trial is by definition…
Journal club: LEADER as the historical anchor Replied, post #40 · Evidence › Journal club · 27 Feb 2026 · 1 like Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later. Happy to be…
Revisiting: Language barriers in accessing a prescription abroad Replied, post #133 · Access › International · 27 Feb 2026 · 23 likes Picking up post #130: that is the part I would want checked first. The reason Language barriers in accessing is hard to answer is that the obvious measurement and the…
Preprint servers and what screening they do Replied, post #62 · Evidence › Preprints · 20 Feb 2026 · 8 likes Peer review catches some things reliably — missing methods, unsupported conclusions, statistical mistakes of the obvious kind — and misses others routinely. Knowing…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #54 · Analytics › Impurities & related substances · 17 Feb 2026 · 24 likes Aggregates may be a multiple of the monomer mass and may not elute at all under a standard method. What does not come off the column does not appear in the area…
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #7 · Analytics › Impurities & related substances · 8 Feb 2026 · 31 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #50 · Documentation › Doc review · 16 Jan 2026 · 0 likes Reviewing your own nomination is fine and is not sufficient. Somebody else has to read it for the process to mean anything.
[2026 update] Does a peptide degrade silently, with no visual change? Replied, post #8 · Practice › Storage & stability · 28 Dec 2025 · 2 likes Where I part company with post #6, and it is a narrow parting. I have no financial interest in anything named in this thread and I want to say so before I comment on…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #24 · Pharmacology › Receptor biology · 23 Dec 2025 · 0 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #12 · Practice › Side effects · 31 Oct 2025 · 20 likes Post #10 and I disagree about the size of the effect, not about the direction. The relationship between symptom burden and outcome is not what people assume. Feeling…
Where to report an adverse event officially, by region — a second dataset Replied, post #23 · Safety › Adverse events · 15 Oct 2025 · 19 likes Pancreatitis is a genuine serious adverse event to know: severe epigastric pain, back pain, elevated lipase (≥3× upper limit of normal). If this constellation appears,…
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #105 · Compounds › Cagrilintide & amylin analogues · 6 Oct 2025 · 17 likes Narrowing post #103, because the general version has more than one answer. The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #57 · Practice › Dosing & titration · 28 Sep 2025 · 3 likes Dose and effect are not linear across the studied range for every compound in this class. Assuming a doubled dose gives a doubled effect is the reasoning error behind…
When a preprint is the best available evidence and we say so Replied, post #112 · Evidence › Preprints · 29 Aug 2025 · 0 likes The useful distinction on preprint is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has error bars.
System suitability injections: if they failed, the run did not happen Replied, post #26 · Analytics › HPLC & UHPLC · 26 Aug 2025 · 0 likes Peaks that do not elute do not appear in the area percentage. Aggregates and strongly retained species can be entirely invisible to a standard method, which is a…
Thyroid function tests during substantial weight change Replied, post #38 · Clinical › Bloodwork · 22 Aug 2025 · 6 likes If you are new and reading this thread for the answer to thyroid function tests during substantial: the answer is conditional, the conditions are in the third reply,…
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #13 · Evidence › Journal club · 11 Aug 2025 · 0 likes I would put moderate confidence on the mainstream reading of orforglipron phase 2 and no more. That is not scepticism for its own sake; it is where the sourcing…
When to stop reading forums, including this one Replied, post #9 · Wellbeing › Mental health · 26 Jul 2025 · 13 likes Nothing here is medical advice and several members in this subcategory say plainly that they are describing their own experience only.
Canadian access and provincial variation — one year on Replied, post #28 · Regional › North America · 25 Jul 2025 · 24 likes On Canadian access and provincial variation I would separate what is worth knowing from what is worth acting on. The first list is long and the second is short, and…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #20 · Sourcing › Vendor reports · 3 Jul 2025 · 8 likes Sensible. I would want the same detail before I acted on it either.
Follow-up: Requesting a page: what makes a good request Replied, post #48 · Documentation › Wiki requests · 13 Jun 2025 · 7 likes Scope creep: if you think a page is attempting too much and should be split into multiple pages, that is a reasonable suggestion. If that reads as pedantic, it is, and…
Follow-up: What other technical communities get right that we do not Replied, post #108 · Lounge › Off topic · 24 May 2025 · 0 likes Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not. That is what I would do. It may not be what is correct.
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #36 · Evidence › Trials · 23 May 2025 · 0 likes Non-inferiority margins are chosen, and the choice is an argument rather than a fact. A wide margin can make a worse treatment look acceptable. The step people skip is…
Hepatic steatosis: what the MASH trial evidence supports Replied, post #44 · Clinical › Comorbidities · 19 May 2025 · 6 likes Obstructive sleep apnoea: SURMOUNT-OSA used an objective endpoint, the apnoea-hypopnoea index. Reduction was substantial. Whether the benefit is weight loss or a direct…
Pregnancy as an absolute contraindication Replied, post #19 · Safety › Contraindications · 17 May 2025 · 12 likes Pregnancy appears in the labelling for this class and the position is stated explicitly rather than left to inference. That is the version I would defend. It is not the…
Pages past their review date, listed — does this still hold? Replied, post #17 · Meta › Wiki maintenance · 8 May 2025 · 6 likes Requesting a review date change rather than a content change. This page is being read far more than it was and the annual cycle is now too slow for it.
Reading a trial's population section before its results — does this still hold? Replied, post #79 · Evidence › Trials · 8 May 2025 · 0 likes Narrowing post #76, because the general version has more than one answer. Absolute and relative effects answer different questions. Write down the event rate in each…
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #111 · Compounds › Cagrilintide & amylin analogues · 7 May 2025 · 26 likes Cagrilintide is a long-acting amylin analogue, which puts it in a different mechanistic family from the incretin agonists it is usually discussed alongside. Amylin…
Coverage for the indication versus for the drug Replied, post #37 · Access › Insurance & coverage · 21 Apr 2025 · 16 likes Nothing here is legal or medical advice, and appeal processes differ enough by jurisdiction and payer that specifics do not transfer. Not a strong opinion, just a…
Review cadence: how often is a page actually re-checked? Replied, post #15 · Documentation › Doc review · 10 Apr 2025 · 0 likes The four criteria are that the question recurs, that the content is correct and sourced or labelled as community practice, that somebody will be named as maintainer…
Reading a chromatogram someone posted without axes Replied, post #16 · Analytics › HPLC & UHPLC · 30 Mar 2025 · 1 like Gradient delay volume differs between instruments and shifts the whole chromatogram. It is why a transferred method rarely reproduces retention times exactly on a…
Charge states for a 4 kDa peptide, worked through Replied, post #146 · Analytics › Mass spectrometry · 18 Mar 2025 · 7 likes The arithmetic in post #143 is right; the assumption feeding it is the part to check. Adding a reference point for charge states. Mine is a single case, collected…
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #24 · Sourcing › Independent verification · 5 Mar 2025 · 1 like Taking post #23 at face value and following it one step further. Repeat determination on the same product line months apart is the measurement that speaks to…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #30 · Sourcing › Regulatory · 28 Feb 2025 · 0 likes Post #27 is right about the mechanism and I think understates the practical bit. Generic or biosimilar entry depends on patent and exclusivity positions that are…
Coming back to: Official shortage notices and what they authorise Replied, post #39 · Access › Shortages · 24 Feb 2025 · 22 likes An observation about Official shortage notices that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than…
A promotion I argued against, and why I lost Replied, post #87 · Documentation › Doc review · 6 Feb 2025 · 8 likes Appreciated. The plain phrasing does more work here than a longer post would.
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #98 · Evidence › Journal club · 19 Jan 2025 · 17 likes I think the SURPASS-2 question is answerable and has not been answered, which is a more optimistic position than most of this thread.
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #26 · Compounds › Secretagogues & GH axis · 11 Jan 2025 · 1 like A methods point on well-designed human trial rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference…
Follow-up: Individual participant data versus aggregate data Replied, post #66 · Evidence › Meta-analyses · 10 Jan 2025 · 3 likes Post #63 is the version of this I will quote in future. One addition. Double extraction with disagreement resolution is standard and is worth checking for, because…
Request: a diff view for wiki revisions Replied, post #31 · Meta › Feature requests · 15 Dec 2024 · 30 likes Adding thanks rather than a view. I do not have a view worth the space.
EMA product information as a primary source — does this still hold? Replied, post #105 · Regional › European Union · 17 Nov 2024 · 14 likes No disagreement from me. Posting only so the question does not look ignored.
How to ask for a dose change without antagonising anyone — what changed since Replied, post #9 · Clinical › Prescriber conversations · 26 Oct 2024 · 1 like A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. That is a description of practice, not a…
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #16 · Clinical › Comorbidities · 3 Oct 2024 · 16 likes Reading back through the Type 2 diabetes threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That…
Correlation in a self-tracked dataset: what it can support Replied, post #139 · Research Methods › Statistics · 25 Aug 2024 · 28 likes P-values and significance: p
Chronic kidney disease and the FLOW result Replied, post #14 · Clinical › Comorbidities · 14 Aug 2024 · 31 likes Post #13 is the version of this I will quote in future. One addition. Bariatric surgery history: altered anatomy after surgery affects absorption. That matters for oral…